Related references
Note: Only part of the references are listed.Methodological considerations on estimating medication adherence from self-report, electronic monitoring and electronic healthcare databases using the TEOS framework
Alexandra L. Dima et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2023)
Pharmacometabonomic association of cyclophosphamide 4-hydroxylation in hematopoietic cell transplant recipients
Jeannine S. McCune et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2022)
Exploring Stem Cell Transplanted Patients' Perspectives on Medication Self-Management and Electronic Monitoring Devices Measuring Medication Adherence: A Qualitative Sub-Study of the Swiss SMILe Implementation Science Project
Janette Ribaut et al.
PATIENT PREFERENCE AND ADHERENCE (2022)
A wearable electrochemical biosensor for the monitoring of metabolites and nutrients
Minqiang Wang et al.
NATURE BIOMEDICAL ENGINEERING (2022)
Lipidomics of cyclophosphamide 4-hydroxylation in patients receiving post-transplant cyclophosphamide
Sandi L. Navarro et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2022)
Current Definitions and Clinical Implications of Biomarkers in Graft-versus-Host Disease
Alan Bidgoli et al.
TRANSPLANTATION AND CELLULAR THERAPY (2022)
Rates and Predictors of Nonadherence to the Post-Allogeneic Hematopoietic Cell Transplantation Medical Regimen in Patients and Caregivers
Donna M. Posluszny et al.
TRANSPLANTATION AND CELLULAR THERAPY (2022)
Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial
Ephraim J. Fuchs et al.
BLOOD (2021)
Feasibility of geriatric assessment before transplant conditioning regimen in older HCT recipients
Kai Littlejohn et al.
BONE MARROW TRANSPLANTATION (2021)
TEOS: A framework for constructing operational definitions of medication adherence based on Timelines-Events-Objectives-Sources
Alexandra L. Dima et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Development of an integrated model of care for allogeneic stem cell transplantation facilitated by eHealth-the SMILe study
Lynn Leppla et al.
SUPPORTIVE CARE IN CANCER (2021)
A Prospective Survey of Outpatient Medication Adherence in Adult Allogeneic Hematopoietic Stem Cell Transplantation Patients
Lauren L. Ice et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Association of Antiepileptic Medications with Outcomes after Allogeneic Hematopoietic Cell Transplantation with Busulfan/Cyclophosphamide Conditioning
Jeannine S. McCune et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Standardized Semi-structured Psychosocial Evaluation before Hematopoietic Stem Cell Transplantation Predicts Patient Adherence to Post-Transplant Regimen
Adrienne D. Mishkin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial
Brenda M. Sandmaier et al.
LANCET HAEMATOLOGY (2019)
Report from the American Society of Transplantation Psychosocial Community of Practice Adherence Task Force: Real-world options for promoting adherence in adult recipients
Larissa Myaskovsky et al.
CLINICAL TRANSPLANTATION (2018)
Medication adherence among allogeneic hematopoietic stem cell transplant recipients: a pilot single-center study
J. Lehrer et al.
BONE MARROW TRANSPLANTATION (2018)
Medication nonadherence to immunosuppressants after adult allogeneic haematopoietic stem cell transplantation: a multicentre cross-sectional study
B. Gresch et al.
BONE MARROW TRANSPLANTATION (2017)
Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the future
A. S. Darwich et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Medication Adherence in Hematopoietic Stem Cell Transplantation: A Review of the Literature
Caroline F. Morrison et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II
Jeannine S. McCune et al.
CLINICAL PHARMACOKINETICS (2016)
Pharmacokinetics, Pharmacodynamics and Pharmacogenomics of Immunosuppressants in Allogeneic Haematopoietic Cell Transplantation: Part I
Jeannine S. McCune et al.
CLINICAL PHARMACOKINETICS (2016)
A scoping review of studies comparing the medication event monitoring system (MEMS) with alternative methods for measuring medication adherence
Mohamed El Alili et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice
T. Ruutu et al.
BONE MARROW TRANSPLANTATION (2014)
Differences in health behaviour between recipients of allogeneic haematopoietic SCT and the general population: a matched control study
M. Kirsch et al.
BONE MARROW TRANSPLANTATION (2014)
Adherence to outpatient oral medication regimens in adolescent hematopoietic stem cell transplant recipients
Meghari E. McGrady et al.
EUROPEAN JOURNAL OF ONCOLOGY NURSING (2014)
Nonrelapse Mortality and Mycophenolic Acid Exposure in Nonmyeloablative Hematopoietic Cell Transplantation
Cara L. McDermott et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Population Pharmacokinetics and Dose Optimization of Mycophenolic Acid in HCT Recipients Receiving Oral Mycophenolate Mofetil
H. Li et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Improving the transition of highly complex patients into the community: impact of a pharmacist in an allogeneic stem cell transplant (SCT) outpatient clinic
Ruth Chieng et al.
SUPPORTIVE CARE IN CANCER (2013)
Evaluation of Oral Beclomethasone Dipropionate for Prevention of Acute Graft-versus-Host Disease
Paul J. Martin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Personalized Dosing of Cyclophosphamide in the Total Body Irradiation-Cyclophosphamide Conditioning Regimen: A Phase II Trial in Patients With Hematologic Malignancy
J. S. McCune et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation
Y. Le Meur et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Relationship of mycophenolic acid exposure to clinical outcome after hematopoietic cell transplantation
P Jacobson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Routine screening for psychosocial distress following hematopoietic stem cell transplantation
SJ Lee et al.
BONE MARROW TRANSPLANTATION (2005)
Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens
N Bleyzac et al.
BONE MARROW TRANSPLANTATION (2001)
Pharmacokinetics of intravenous mycophenolate mofetil after allogeneic blood stem cell transplantation
A Jenke et al.
CLINICAL TRANSPLANTATION (2001)
Share Paper
